Leidos (LDOS) Projected to Post Quarterly Earnings on Tuesday

Leidos (NYSE:LDOS) is projected to announce its earnings results before the market opens on Tuesday, February 11th. Analysts expect the company to announce earnings of $2.24 per share and revenue of $4.13 billion for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Leidos Price Performance

Shares of NYSE LDOS opened at $141.64 on Tuesday. Leidos has a 1-year low of $108.97 and a 1-year high of $202.90. The company has a current ratio of 1.23, a quick ratio of 1.15 and a debt-to-equity ratio of 0.87. The firm’s 50-day moving average price is $152.04 and its 200-day moving average price is $158.14. The firm has a market capitalization of $18.90 billion, a P/E ratio of 16.13, a P/E/G ratio of 0.93 and a beta of 0.66.

Insider Activity at Leidos

In other Leidos news, Director Surya N. Mohapatra sold 2,748 shares of the company’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $194.97, for a total value of $535,777.56. Following the sale, the director now owns 20,001 shares in the company, valued at approximately $3,899,594.97. This represents a 12.08 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Noel B. Geer bought 2,000 shares of the firm’s stock in a transaction dated Wednesday, November 20th. The stock was purchased at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the transaction, the director now owns 2,000 shares of the company’s stock, valued at approximately $322,260. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.96% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms have issued reports on LDOS. Royal Bank of Canada upped their target price on shares of Leidos from $145.00 to $180.00 and gave the company a “sector perform” rating in a research note on Wednesday, October 30th. Barclays boosted their price objective on Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Wells Fargo & Company cut their price objective on shares of Leidos from $205.00 to $199.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. UBS Group assumed coverage on shares of Leidos in a report on Monday, December 2nd. They issued a “neutral” rating and a $182.00 target price on the stock. Finally, Citigroup raised their price objective on shares of Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Five research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $179.07.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.